Novartis subsidiary Navigate Biopharma announced on Friday that it has formed a strategic collaboration with Becton Dickinson to help develop and commercialize companion diagnostics and clinical decision-making tools using flow cytometry.

As a global company with a broad range of businesses, operations in over 160 countries and 115,000 people around the world, diversity is inherent to our business and organization.

Laborie Medical Technologies has entered a definitive agreement for the acquisition of medical device company Urotronic in a deal valued at up to $600m.

On September 6th, Roche Diagnostics China announced its official partnership with Deep Informatics. They will jointly launch a pathology artificial intelligence (AI) assisted interpretation algorithm product, further promoting the digitalization and intelligent transformation of pathology diagnosis in China, providing strong support for the development of personalized precision diagnosis and treatment.

Circular Genomics, the global leader in circular RNA biomarkers for precision psychiatry, has announced a partnership with leading Alzheimer’s genomics expert Dr. Carlos Cruchaga to explore the role of circRNAs as blood biomarkers for early diagnosis and treatment of Alzheimer’s Disease.

US Food and Drug Administration officials on Wednesday released draft guidance outlining the types of predicate device analysis and evidence they will expect in 510(k) clearance applications as they work to modernize the clearance process for medical devices, including in vitro diagnostics.

LabGenomics USA, a subsidiary of South Korean-based diagnostics firm LabGenomics, said Tuesday that it has acquired QDx Pathology for an undisclosed amount.

Abbott (NYSE: ABT) and Bigfoot Biomedical today announced a definitive agreement for Abbott to acquire Bigfoot, a leader in developing smart insulin management systems for people with diabetes.

China Association of In Vitro Diagnostics (CAIVD) and In Vitro Diagnostics Society of China Association for Medical Devices Industry jointly compiled this report.

Centogene finds diagnostic and predictive biomarker for Gaucher disease.

In a recent study published in The Journal of Applied Laboratory Medicine, researchers evaluated the performance of a compact diagnostic assay that can accurately and rapidly diagnose lactose intolerance using capillary blood and buccal swab samples.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Oxford Nanopore Technologies and IQVIA have struck a partnership to broaden access to nanopore sequencing technology, saying it will boost genomics research and patient care.

BioMérieux reported on Friday that its second quarter 2023 revenues increased 5 percent driven by strong momentum in microbiology, its BioFire non-respiratory panel, and industrial applications.

Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended June 30, 2023.